1. Home
  2. VRAX vs RPGL Comparison

VRAX vs RPGL Comparison

Compare VRAX & RPGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.85

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo Republic Power Group Limited Class A Ordinary Shares

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$1.45

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
VRAX
RPGL
Founded
2013
2015
Country
United Kingdom
Singapore
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.3M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
VRAX
RPGL
Price
$2.85
$1.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
481.2K
562.6K
Earning Date
06-12-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$21.40
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.21
52 Week High
$13.19
$13.06

Technical Indicators

Market Signals
Indicator
VRAX
RPGL
Relative Strength Index (RSI) 50.61 41.73
Support Level $2.55 $0.30
Resistance Level $3.10 $1.99
Average True Range (ATR) 0.19 0.39
MACD -0.02 -0.05
Stochastic Oscillator 30.61 18.89

Price Performance

Historical Comparison
VRAX
RPGL

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

Share on Social Networks: